Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Protagonist Therapeutics Inc (NQ: PTGX )

33.93 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 33.93
Bid (Size) 30.67 (1)
Ask (Size) 35.32 (1)
Prev. Close 33.93
Today's Range 33.93 - 33.93
52wk Range 12.80 - 50.54
Shares Outstanding 47,728,227
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate
Protagonist Therapeutics Inc(NASDAQ: PTGX) hasselected PN-235 (JNJ-77242113) as the final candidatefor all clinical ... 
Tags Benzinga Small Cap Health Care
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Protagonist to Discontinue ... 
Tags BMY ESPR LLY
From Benzinga

Performance

YTD
+73.13%
+73.13%
1 Month
-2.04%
-2.04%
3 Month
-26.82%
-26.82%
6 Month
-3.95%
-3.95%
1 Year
+38.79%
+38.79%

More News

Read More
Noteworthy Tuesday Option Activity: SONO, QGEN, PTGX
Tags Stocks
From Market News Video
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
Tags Benzinga Analyst Ratings Market News
From Benzinga
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
Tags GME WIMI BTBT
From Benzinga
Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop
Tags PALT PTGX Uncategorized
From InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
Tags PALT Penny Stocks Top Stories
From Benzinga
Protagonist Therapeutics Trying To Close In On Key Technical Benchmark
From Investor's Business Daily
How The Pieces Add Up: SMMV Headed For $43
Tags ETFs
From ETF Channel
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
Tags PTGX Recent Press Releases Market News
From Motley Fool
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
Tags PTGX BZI/AAR Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.